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Abstract
IQGAP1 is a scaffold protein that interacts with proteins of the cytoskeleton and the intercellular adhesion complex. In
podocytes, IQGAP1 is associated with nephrin in the glomerular slit diaphragm (SD) complex, but its role remains ill-defined.
In this work, we investigated the interaction of IQGAP1 with the cytoskeleton and SD proteins in podocytes in culture, and
its role in podocyte migration and permeability. Expression, localization, and interactions between IQGAP1 and SD or
cytoskeletal proteins were determined in cultured human podocytes by Western blot (WB), immunocytolocalization (IC),
immunoprecipitation (IP), and In situ Proximity Ligation assay (IsPL). Involvement of IQGAP1 in migration and permeability
was also assessed. IQGAP1 expression in normal kidney biopsies was studied by immunohistochemistry. IQGAP1 expression
by podocytes increased during their in vitro differentiation. IC, IP, and IsPL experiments showed colocalizations and/or
interactions between IQGAP1 and SD proteins (nephrin, MAGI-1, CD2AP, NCK 1/2, podocin), podocalyxin, and cytoskeletal
proteins (a-actinin-4). IQGAP1 silencing decreased podocyte migration and increased the permeability of a podocyte layer.
Immunohistochemistry on normal human kidney confirmed IQGAP1 expression in podocytes and distal tubular epithelial
cells and also showed an expression in glomerular parietal epithelial cells. In summary, our results suggest that IQGAP1,
through its interaction with components of SD and cytoskeletal proteins, is involved in podocyte barrier properties.
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Introduction
Podocytes are epithelial cells with long foot processes that
interdigitate around glomerular capillaries. A specialized protein
complex junction between foot processes forms the slit diaphragm
which is crucial for glomerular integrity. Nephrin is the major
structural component of the slit diaphragm [1]. Other proteins
such as podocin, phospholipase Ce1, CD2AP, a-actinin-4, CLIC5
and the scaffold proteins NCK 1 and 2 are also important for
maintaining the slit diaphragm’s integrity. Defects in the
expression of one of these proteins induce proteinuria resulting
from effacement of foot processes and loss of glomerular barrier
integrity [2,3,4,5,6].
IQGAP1, a scaffold protein involved in actin remodelling has
been identified as being associated with nephrin in podocyte foot
processes [7,8]. In humans, IQGAP1 is a 189 kDa protein [9],
localized in the cytoplasm and also associated with the cell
membrane [7,8]. IQGAP1 consists of several interaction domains:
a calponin homology domain which binds filamentous (F)-actin, a
WW domain interacting with ERK1-2 [10], an IQ domain
interacting with calmodulin [11] and MEK1-2 [12], and a GRD
domain (a GAP related domain, without GTPase activity)
interacting with the Rho GTPases, Cdc42 and Rac1 [13,14,15].
The C-terminus domain interacts with CLIP170 [16], APC [17],
b-catenin [18] and E-cadherin [19,20].
By interacting with actin and the Rho GTPases Cdc42 and
Rac1, IQGAP1 contributes to the actin network formation
[21,22,23]. Moreover, IQGAP1 connects the actin network to
microtubules by binding to APC and CLIP170 [16,17]. IQGAP1
can also interact with E- and VE-cadherin [24] and b-catenin at
the cellular junctions of epithelial and endothelial cells. By
interacting with these different proteins, IQGAP1 plays a major
role in cellular migration, cytoskeleton organization and linkage
between actin cytoskeleton and microtubules.
Apart from being associated with nephrin in the proximity of
the glomerular slit diaphragm in human and rats [7,8], IQGAP1 is
also present in migrating junctional complexes during rat
glomeruli development, with different cell localizations over time:
IQGAP1 is detected at cell-cell junctions between the earliest
forming podocytes and migrates with the junctional complexes of
differentiating podocytes. In the late capillary loop stage, IQGAP1
accumulates in foot processes where it colocalizes with podoca-
lyxin [8].
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In this study, we have analyzed the protein partners of IQGAP1
in human cultured podocytes but also IQGAP1 involvement in
podocyte migration and permeability, as well as IQGAP1
localization and expression on human normal kidney tissue
sections.
Results
Expression of IQGAP1 in Human Conditionally
Immortalized Podocytes
To study IQGAP1 expression in podocytes, we performed
Western blot experiments. Cells were initially grown at the
permissive temperature of 33uC - day 0 (D0) -, and were incubated
up to 16 days (D16) at the non permissive temperature of 37uC
(Details on morphological differences are available in Figure S1)
[25,26]. IQGAP1 protein was expressed in undifferentiated cells
and its expression level increased, significantly in differentiated
cells (p,0.01, n = 6) (Figure 1A and 1B). The expression of
podocyte markers, nephrin, podocin, and podocalyxin also tended
to increase during differentiation [25] (Figure 1C). Results are
representative of different experiments (n = 6) and different human
kidney lysates (Figure S2).
Colocalization of IQGAP1 with Proteins of the Slit
Diaphragm
Immunofluorescence experiments were used to study the
subcellular localization of the above proteins in differentiated
podocytes. IQGAP1 was found in the perinuclear area, in cell
extensions and associated to the plasma membrane with a
stronger intensity on podocyte junctions (Figure 2, panel 1a to
1j). IQGAP1 perinuclear labelling, as for other studied proteins
(nephrin, MAGI-1, NCK1 or/and 2), probably corresponded to
endoplasmic reticulum and Golgi apparatus localization. Ne-
phrin was expressed at cell membranes, particularly in podocyte
junctions (Figure 2a, panel 2, arrows) and colocalized with
IQGAP1 (Figure 2a, panels 3 and 4, arrows). MAGI-1 was
localized at cell membrane and cytoplasmic extensions.
Colocalization with IQGAP1 was mainly found in cytoplasmic
extensions (Figure 2b, panel 1-4, arrows). CD2AP and podocin
was only hardly expressed at the cell membrane, with a discrete
colocalization with IQGAP1 (Figure 2c and 2d, panel 1-4,
arrows). NCK 1 or/and 2 are scaffold proteins associated with
nephrin [6]. In cultured podocytes, NCK 1 or/and 2 were
found in the nucleus and at the cell membrane. A weak
colocalization of NCK 1/2 with IQGAP1 was observed at the
cell membrane (Figure 2e, panel 1-4). The a-actinin-4 labelling
was found essentially with a filamentous distribution, evoking
association with actin cytoskeleton, and associated with the cell
membrane. Colocalization with IQGAP1 was preponderant in
the cytoplasm and along the cell membrane (Figure 2f, panel 1-
4, arrows). b-catenin had a similar localization pattern and
colocalized with IQGAP1 at cell-cell contacts (Figure 2g, panel
1-4, arrows). b-actin was found in cytoplasm and associated
with the plasma membrane. b-actin colocalized with IQGAP1
in both sites (Figure 2h, panel 1-4, arrows). The pattern of
filamentous actin localization was similar to b-actin in
podocytes. IQGAP1 and F-actin predominantly colocalized at
the plasma membrane and on actin fibers to a less extent
(Figure 2i, panel 1-4, arrows). As for CD2AP, podocalyxin was
faintly expressed at the podocyte membrane where a detectable
colocalization with IQGAP1 was found (Figure 2j, panel 1–4,
arrows).
Figure 1. Western blot analysis of IQGAP1 expression in
cultured podocyte extracts. (A) Western blot analysis of IQGAP1,
detected at a molecular weight of 180 kD, and b-actin expressions
during podocyte differentiation (top panel). Protein extracts were from
undifferentiated (permissive temperature of 33uC, Day 0 (D0)) and
differentiated (non-permissive temperature of 37uC, Day 16 (D16))
cultured immortalized podocytes. HKL: Human Kidney Lysate; MW:
Molecular weight (kDa). The blot is representative of six independent
experiments. (B) IQGAP1 expression at undifferentiated and differenti-
ated stages. IQGAP1 expression, determined by densitometry, was
plotted and reported to b-actin expression. Data are representative of
six independent experiments. Asterisk, significantly different from
undifferentiated cells (p,0.01, Wilcoxon’s test). (C) Western blot
analysis of nephrin, MAGI-1, CD2AP, podocin, NCK 1/2, a-actinin-4, b-
catenin, podocalyxin and b-actin during podocyte differentiation.
doi:10.1371/journal.pone.0037695.g001
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Interaction Between IQGAP1 and Nephrin, MAGI-1,
CD2AP, Podocin, NCK1 or/and 2, a-actinin-4, b-catenin
and Podocalyxin
In order to characterize IQGAP1 protein interactions in
undifferentiated and differentiated podocytes, IQGAP1 immuno-
precipitation experiments were performed using equal amounts of
total protein, associated with reverse immunoprecipitations. We
first confirmed the interaction between IQGAP1 and nephrin
[7,8], and showed that this interaction occurred both in
undifferentiated and differentiated cells (Figure 3A). We also
found that in undifferentiated and differentiated podocytes
IQGAP1 interacted with MAGI-1 and CD2AP, proteins already
known as interacting with nephrin [27,28] (Figures 3B and 3C).
Interactions between IQGAP1 and podocin or NCK1/2 were
detected in podocytes (Figure 3D and 3E). We also found that
IQGAP1 interacted with a-actinin-4 and b-catenin (Figure 3F and
3G), in undifferentiated and differentiated podocytes. Finally, we
observed an interaction between IQGAP1 and podocalyxin
(Figure 3H), an apical transmembrane protein linked to actin
cytoskeleton via ezrin, expressed in podocyte foot processes and
involved in cell polarity through an indirect interaction with focal
membrane basal adherences [29,30,31].
Cellular Localization of Contacts Between IQGAP1 and
Nephrin, MAGI-1, CD2AP, Podocin, NCK and Podocalyxin
In order to confirm immunoprecipitation experiments and to
study protein interactions within cells, we performed In situ
Proximity Ligation assays, a distance between two proteins of less
than 30–40 nm giving a fluorescent dot signal [32]. To show the
specificity of the interaction, we used podocytes where IQGAP1
expression was down-regulated by small interfering RNA (siRNA)
(see Table 1). First, we analyzed IQGAP1 protein in cells treated
or not with siRNA by Western blot. In cells transfected with
siRNA IQGAP1, IQGAP1 was down-regulated by 75% as
compared with the untransfected podocytes (UT) or with siRNA
Luc (control, Luciferase) transfected podocytes (Figure 4A). siRNA
IQGAP1 transfection induced a cell shape change with actin fibers
disruption (F-actin immunofluorescence, Figure 4B). The In situ
Proximity Ligation assay confirmed interactions between IQGAP1
and proteins of the slit diaphragm complex, nephrin, MAGI-1,
CD2AP, podocin and NCK1/2. Moreover, there was also an
interaction between IQGAP1 and the apical transmembrane
protein podocalyxin (Figure 5).
IQGAP1 Involvement in Podocyte Characteristics
In order to understand the potential role of IQGAP1 in
podocyte physiology, different functional experiments were
performed on cells untransfected or transfected with different
siRNA (Table 1). Two controls were used as previously:
untransfected cells and cells transfected with siRNA Luc. Cells
were used 96 h after transfection. In the migration assay, wounds
in the cell layer were reduced by 8567.5% (median 6 SEM) in
control cells after 48 hours (Figure 6A and 6B). IQGAP1 silencing
significantly reduced podocyte migration (Figure 6C and 6D), after
24 and 48 hours (3064.95%, p,0.05 and 59610%, p,0.01
respectively, two-way repeated measurements ANOVA,
Figure 6E). Analysis on shorter time periods, 6 and 12 hours,
showed no difference between control and siRNA IQGAP1
transfected podocytes. The inhibition of IQGAP1 expression was
conserved during the migration assay (data not shown).
No significant difference was detected between control (un-
transfected cells or siRNA Luc) and siRNA IQGAP1 transfected
podocytes in terms of cell proliferation and cytotoxicity or
adhesion at each time point of the migration assays (Figure 7A
to 7C). Impairment of podocyte migration, in siRNA IQGAP1
transfected cells, is not due to an inhibitory effect on cell
proliferation, cytotoxicity or adhesion. These data were confirmed
with other tests, Live-Dead test, Dead Cell Apoptosis Kit with
Alexa Fluor 488 annexin V and propidium iodide in flow
cytometry experiments (data not shown). Focal adhesion kinase
(FAK) immunofluorescence did not show difference in focal
adhesion sites between control and siRNA IQGAP1 transfected
cells (Figure S3).
A permeability assay was performed in differentiated cells
transfected for 96 h. A significant increase in the podocyte layer
permeability to 70 kDa FITC-dextran was observed at 120
minutes in siRNA IQGAP1 transfected cells compared to control
cells (3.160.4 vs 4.560.5 respectively, p,0.05, two-way repeated
measurements ANOVA, Figure 8).
IQGAP1 Expression in Normal Glomeruli
In order to study IQGAP1 expression in vivo in human
podocytes, IQGAP1 immunohistochemistry experiments were
performed on normal kidney sections (biopsies obtained during
kidney transplantation from living donors, n = 7). To discriminate
between podocytes and other components of glomeruli, nephrin
was used as a specific marker for podocytes (additional DAPI
nuclear staining and nephrin staining data are available in Figure
S4A and S4B). On normal kidney sections, IQGAP1 labelling was
found in podocyte processes and cell bodies (Figure 9A, C, a and c,
plain and fine arrows). IQGAP1 was expressed in glomerular
parietal epithelial cells (bold arrows in Figure 9A and C). IQGAP1
was also expressed in endothelial [33] and distal tubular cells (bold
arrows in Figure 9A and C) but was absent in proximal tubular
cells [34]. Nephrin was expressed in podocytes (Figure 9B and C,
insert b and c, dash arrows). An inconstant colocalization with
IQGAP1 was observed in podocytes (Figure 9C and c, middle and
lower plain and dashed arrows). Indeed, in some glomerular areas,
nephrin and IQGAP1 appeared juxtaposed at the same podocyte
structure rather than directly colocalized (Figure 9c, top arrows).
Similar results were obtained with additional human kidney
sections (Figure S5).
Discussion
In the present report, we demonstrate that apart from being
associated to nephrin in podocytes [7,8], IQGAP1 is associated to
other proteins of the slit-diaphragm complex and of the
cytoskeleton. Furthermore, IQGAP1 is involved in functional
properties of podocytes such as permeability as a cell layer, and
migration.
IQGAP1 expression increased from undifferentiated to differ-
entiated stages, as shown for other slit diaphragm proteins such as
Figure 2. Subcellular localization of IQGAP1 and slit diaphragm proteins or podocalyxin. Double immunolabelling experiments were
performed on cultured differentiated podocytes, and analyzed by confocal microscopy. Column 1: IQGAP1 (red). Column 2: nephrin (a), MAGI-1 (b),
CD2AP (c), podocin (d), NCK 1/2 (e), a -actinin-4 (f), b-catenin (g), b-actin (h), F-actin (i) and podocalyxin (j) (green). Column 3: Colocalization of IQGAP1
and studied proteins, observed as a merge signal in yellow staining or as colocalization points in black color (Column 4) with the Leica analysis
software.
doi:10.1371/journal.pone.0037695.g002
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podocin and nephrin [25]. The down-regulation of IQGAP1
expression in podocytes induces a disorganization of actin
cytoskeleton together with a disruption of actin fibers and cell
shape changes. IQGAP1 is crucial in the cytoskeleton organiza-
tion: several studies reported an inhibition of the actin meshwork
formation, and an alteration in cell adhesion and migration
following the down regulation of IQGAP1 expression [17,21,23].
Therefore, IQGAP1 may be important in the major cytoskeletal
rearrangement occurring during podocyte differentiation and
acquisition of the mature podocyte phenotype [8,35].
Our study first suggests that IQGAP1 is an integral partner of
the nephrin complex and may connect the cytoskeleton with the
slit diaphragm complex, through its interaction with members of
this complex and cytoskeletal proteins. IQGAP1 also colocalized
with b-catenin and MAGI-1, at cell contacts. Depending on the
cell type, IQGAP1 can increase or decrease the strength of the
cell-cell junction through binding to b-catenin [18,19], a cadherin
adaptator protein. Thanks to its interaction with b-catenin,
IQGAP1 may be a modulator of the strength of the interaction
between podocytes. Indeed, podocyte junctions depend on P-
cadherin and its interaction with catenins [36]. Finally, we also
show that IQGAP1 interacted with podocalyxin, a protein
expressed at the apical domain of podocytes, early expressed
during the glomerular development and crucial in determining the
cell polarity [29,30,31]. IQGAP1 is expressed at different sites in
the cell and particularly at the apical area, where its association
with podocalyxin may contribute to associate podocalyxin to
podocyte cytoskeleton. Our study does not allow distinguishing
whether IQGAP1 interactions with these proteins are direct or
indirect. IQGAP1 was shown to bind directly b-catenin [18] and
F-actin [37] in various cell lines. In podocytes, we may speculate
that there is a direct interaction between these proteins and
IQGAP1. Further experiments are needed to answer these
questions.
Among the three podocyte domains usually described (apical,
basal domains and the slit diaphragm) [38], our work shows that
IQGAP1 is expressed in two areas, the slit diaphragm and the
apical domain. Following published data [1,2,3,4,5,6,7,8] and
results from our study, a schematic representation of foot podocyte
processes summarizing IQGAP1 localization and potential inter-
actions in podocytes is proposed in Figure 10.
Functional experiments showed that IQGAP1 has functional
importance in podocyte physiology. First, IQGAP1 was found to
be involved in podocyte migration. Described in other cell types,
the silencing of IQGAP1 expression modifies its interactions with
proteins as APC, ARP 2/3, N-WASP or CLIP170 and induces
actin cytoskeleton disorganization with microtubule stabilization
defect. This impairment results in trafficking abnormalities of
tubulin units, inhibition of the actin meshwork formation at the
leading edge front and then cell motility defect
[16,17,21,22,23,39]. Podocytes are motile cells around the
glomerular basement membrane [40]. An alteration of podocyte
motility is associated to proteinuria [41]. For this reason, the
putative role of IQGAP1 in the motility of podocytes was
important to clarify. The lack of a significant effect of IQGAP1
inhibition by RNA interference on podocyte adhesion to culture
plates after silencing suggests that IQGAP1 is dispensable for
podocyte adhesion to culture plates. This may due to redundancy
with other IQGAP family member, such as IQGAP2 also involved
in cytoskeleton regulation [22] or redundancy with other adhesion
mechanisms to culture plates. Our results also show that IQGAP1
silencing induces a loss of podocyte layer permeability. IQGAP1
involvement in the control of endothelial cell permeability has
been reported [42]. This modification may be due to podocyte
Figure 3. IQGAP1 interactions with proteins of the slit
diaphragm and podocalyxin. IQGAP1 immunoprecipitation exper-
iments were performed with undifferentiated podocytes (D0, 33uC) and
differentiated podocytes (D16, 37uC), using equal amounts of total
protein. The irrelevant antibody against tristetraprolin was used in
control immunoprecipitations (Ctl). (A) Interaction between IQGAP1 and
nephrin (data are representative of 6 independent experiments). (B to
H) Interactions between IQGAP1 and MAGI-1, CD2AP, podocin, NCK1/2,
a-actinin-4, b-catenin and podocalyxin (Data are representative of 5
independent experiments, 6 for podocalyxin).
doi:10.1371/journal.pone.0037695.g003
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shape change linked to IQGAP1 contribution to the actin
cytoskeleton remodelling. Podocyte cytoskeleton remodelling is
critical in foot processes effacement and slit diaphragm disruption
[5,43]. A defect of IQGAP1 expression may impair interactions
between the slit diaphragm and cytoskeleton, first step of foot
processes effacement. Then, IQGAP1 may be important in the
glomerular barrier integrity and in glomerular disease pathophys-
iology, through its contribution to key podocyte characteristics
(podocyte plasticity, migration and permeability). Studies on tissue
sections from patients suffering from minimal change disease, focal
and segmental glomerulosclerosis or diabetes may be interesting to
clarify the putative role of IQGAP1 in pathogenesis. Our
preliminary results of IQGAP1 expression on pathological human
tissue sections are too variable from patient to patient to conclude
(data not shown). However, unlike other proteins such as nephrin,
podocin, PLCe1, CD2AP, a-actinin-4, or NCK [1,3,4,5,6] which
are crucial in glomeruli formation and in the development of
congenital nephropathies, mutant IQGAP1 mice present only
Figure 4. Effect of the down regulation of IQGAP1 expression on F- actin network. (A) IQGAP1 Western blot analysis showing IQGAP1
expression in podocytes transfected with siRNA IQGAP1 as compared with untransfected podocytes (UT) or podocytes transfected with siRNA
directed at luciferase (Luc). (B) F-actin labelling after siRNA IQGAP1 transfection in comparison to control cells (untransfected cells). Scale bars, 50 mm.
doi:10.1371/journal.pone.0037695.g004
IQGAP1 in Podocytes
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gastric hyperplasia without renal phenotype including proteinuria
[44]. IQGAP family members, IQGAP1, IQGAP2 and IQGAP3,
present a high degree of homology. In mutant IQGAP1 mice, a
functional redundancy of IQGAP2 (expression level of IQGAP2 in
IQGAP1 deficient mice is not altered) or overexpression of
IQGAP3 could blunt the renal effects of IQGAP1 expression and/
or function alterations.
In conclusion, IQGAP1, a scaffold protein, is expressed by
human podocytes in culture, where it interacts with several
proteins of the slit diaphragm nephrin, MAGI-1, CD2AP,
podocin, NCK1/2, with proteins of the actin cytoskeleton, a-
actinin-4 and b-actin, with b-catenin, and with the apical protein
podocalyxin. Down-regulation of IQGAP1 expression diminished
podocyte migration properties, and increased podocyte layer
permeability. Through its connections with foot process cytoskel-
eton and slit diaphragm proteins, IQGAP1 may control key
aspects of podocyte biology and may be important in the
pathophysiology of glomerular diseases.
Methods
Cell Culture
The podocyte cell line has been previously described [25,26].
The cells were obtained from human nephrectomy specimen
without glomerular disease and conditionally immortalized by the
use of the temperature-sensitive large T antigen-SV40 transgene.
These cells were fully differentiated after a switch from 33uC
(permissive, proliferative temperature) to 37uC (non permissive,
differentiating temperature) for 16 days. Cells were cultured in
RPMI 1640 medium supplemented with 10% fetal calf serum
(FCS), insulin (10 mg/ml, Sigma-AldrichH, Lyon, France), trans-
ferrin (5,5 mg/ml, Sigma-AldrichH), selenium (5 ng/ml, Sigma-
AldrichH) and Penicillin-Streptomycin 1X (100X, Invitrogen,
Cergy Pontoise, France). Flasks were coated with collagen I rat
rail (67 mg/ml, Sigma-AldrichH).
Antibodies
Primary and secondary antibodies used in this study are listed in
Tables 2 and 3.
Protein Extraction
Cells were washed in phosphate buffer saline (PBS) and scraped.
After centrifugation at 1,200 g for 5 min, the cell pellet was
resuspended in lysis buffer (10 mM Tris HCl pH 7.5, 5 mM
EDTA, 80 mM NaCl, 50 mM NaF, 1% Triton X100) with 5ml/
ml protease inhibitor (Sigma-AldrichH) and 50 UI/ml desoxyri-
bonuclease I (Invitrogen). The suspension was mixed for 1 h at
4uC and then centrifuged at 15,000 g, for 15 minutes, at 4uC. The
supernatant was analyzed.
For Western blot analysis, human kidney lysates from nephrec-
tomy specimen without nephropathy were used as control.
Protein quantification was performed using a Bradford assay
(Biorad, Marnes-la-Coquette, France) using Bovine Serum Albu-
min (BSA) as standard.
Western Blotting
SDS-PAGE with 6 or 10% acrylamide was performed. A total
of 20 mg of extracted protein were loaded in each lane. After
protein transfer on nitrocellulose, membranes were blocked with
TBST (10 mM Tris HCl pH 7.5, 140 mM NaCl, 0.1% Triton
X100) and 5% BSA, and then incubated with primary antibodies
Figure 5. Cellular localization of interactions between IQGAP1
and different proteins of the slit diaphragm: In situ Proximity
Ligation assay. In situ Proximity Ligation assays confirmed in cells the
interactions between IQGAP1 and nephrin, MAGI-1, CD2AP, podocin,
NCK1/2 and podocalyxin. Cells were transfected with siRNA Luc (Luc) or
siRNA IQGAP1 (siRNA).
doi:10.1371/journal.pone.0037695.g005
Table 1. siRNA used in the study.
siRNA Effect Sequence
siRNA 672 Inhibition UGAAGCUAUUGACCGUAGA[TT]
siRNA 3014 Inhibition UCUUCACACUCUACAACUA [TT]
siRNA Luc Control CGUACGCGGAAUACUUCGA[TT]
doi:10.1371/journal.pone.0037695.t001
IQGAP1 in Podocytes
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overnight, at 4uC (Table 2). After several washes with TBST, the
membrane was incubated for 1 h at room temperature with the
appropriate secondary antibodies conjugated to an IR Dye at 1/
5000 dilution (Table 3). After final washes, the membranes were
visualised using an Odyssey fluorescence imager (LI-COR
Biosciences, Courtaboeuf, France). In some experiments a swine
anti rabbit immunoglobulin conjugated to horse-radish perox-
ydase (HRP) was used as secondary antibody. The detection was
performed using an enhanced chemiluminescent substrate (Pierce,
Brebie`res, France) and an Odyssey fluorescence imager or film.
Densitometry of signals was performed using the Quantity One
software (Bio-Rad).
Immunoprecipitation
500 mg of protein extracts were precleared with 50 ml of protein-
G Sepharose beads (Sigma-AldrichH) for 1 h at 4uC. Then,
podocyte lysates were incubated overnight at 4uC with 2 mg/ml of
anti-IQGAP1 polyclonal antibody or 3 mg/ml of the indicated
antibodies (for the reverse IP). 40 ml of protein-G Sepharose beads
were added for 2 h at 4uC. Beads were washed extensively with
Figure 6. Involvement of IQGAP1 in podocyte migration. To assess the role of IQGAP1 in cell migration, migrations assay were performed with
control cells (Figure 6A and B) compared to siRNA IQGAP1 transfected cells (Figure 6C and D). Cell migration was evaluated during 48 hours with
sequential images acquisitions. Wound closure was expressed as the percentage of cellularized surface (data are representative of 5 independent
experiments, Figure 6E). Control: control cells; siRNA: siRNA IQGAP1 transfected podocytes.
doi:10.1371/journal.pone.0037695.g006
IQGAP1 in Podocytes
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37695
cold lysis buffer. Samples boiled in SDS PAGE sample buffer were
then used for Western blotting experiments. IP controls were
realized, in same conditions, with an irrelevant polyclonal
antibody (rabbit polyclonal anti Tristetraprolin, a protein not
interacting with IQGAP1 and proteins analyzed in this work).
Immunofluorescence
Cells cultivated on coverslips were fixed in 3% paraformal-
dehyde in Cytoskeleton Buffer (10 mM MES pH 6.1, 150 mM
NaCl, 5 mM EGTA, 5 mM MgCl2, 5 mM glucose) for 10 min.
After several washes in TBS (TBST without Triton X100), cells
were permeabilized 30 sec in 0.1% Triton X100, washed in
Figure 7. Involvement of IQGAP1 in podocyte proliferation, viability and adhesion. Influence of down regulation of IQGAP1 on cell
proliferation and viability (Figure 7A and 7B, n = 5, Two-way repeated measurements ANOVA). Cell survival was not altered by transfection. Increase of
cytotoxicity was not the course of the migration defect. Podocyte adhesion after down regulation of IQGAP1 (Figure 7C, n = 3, Wilcoxon test).
Adhesive properties of podocytes were conserved after siRNA IQGAP1 transfection. Control: control cells; siRNA: siRNA IQGAP1 transfected
podocytes.
doi:10.1371/journal.pone.0037695.g007
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TBS and blocked with TBS containing 1% Bovine Serum
Albumin (BSA) and 1% Fetal Calf Serum (FCS). Cells were
incubated with the appropriate primary antibody, at a 1/100
dilution (except for nephrin at a 1/50 dilution) (Table 2) in
blocking buffer, for 2 h, at room temperature. After several
washes, cells were incubated with the appropriate secondary
antibody or Alexa FluorH 594 phalloı¨din (Molecular ProbesH,
Invitrogen) at a 1/200 dilution, for 1 h at room temperature
(Table 3). After several washes, nuclei were labelled with DAPI
solution (dilution 1/1000) for 1 min. Then, coverslips were
mounted on slides using Fluoromount-G (Southern Biotech,
USA). Labelling were analysed using a confocal microscope
(Leica).
Small Interfering RNA (siRNA) Experiments
400,000 podocytes were seeded on a 6 cm culture dish.
Differentiated podocytes were double transfected with siRNA
IQGAP1using the lipofectant RNAiMax (Invitrogen): briefly,
7.5 ml of the lipofectant were mixed with 80 pmol of siRNA in
1 ml of Opti MEM. The mix was added to 4 ml of complete
media without antibiotics to the dishes. Cells were incubated
overnight at 37uC and 5% CO2. The following day, the same
concentrations of lipofectant and siRNA in 1 ml of Opti MEM
Figure 8. Permeability assay. Permeability assays were performed
by quantification of FITC-labelled dextran (70 kDa) passage through a
podocyte layer seeded in a TranswellH. The fluorescence was measured
at sequential times with a WallacH plate reader. The down-regulation of
IQGAP1 expression in podocytes by siRNA induced an increase of the
dextran flux across the podocyte layer (data are representative of 4
independent experiments). Control: control cells; siRNA: siRNA IQGAP1
transfected podocytes.
doi:10.1371/journal.pone.0037695.g008
Figure 9. IQGAP1 glomerular expression and localization in normal kidney tissue. In normal glomeruli, IQGAP1 labelling (green, Panel A, a)
was continuous, corresponding to podocytes (plain and fine arrowsR), as was nephrin staining (red, Panel B and b, dashed arrow ? ). The expression
in parietal epithelial, endothelial and distal tubular cells in normal glomeruli is shown respectively by bold arrows in Panel A and C. Panel C showed
the co-expression of IQGAP1 and nephrin. Scale bars, 50 mm. Panels a, b and c are enlarged images of the boxed areas in panels A, B and C
respectively. Results shown are representative of paraffin kidney sections from 7 normal kidneys (Results of the 6 other kidneys are available in Figure
S5). Scale bar, 50 mm. Analysis was performed with a confocal microscope (Leica). Microscope sections, 0.5 mm. Magnification, X40.
doi:10.1371/journal.pone.0037695.g009
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were added to the dishes. Cells were used between 72 h and 96 h
after the second transfection. The sequences of the siRNA
targeting IQGAP1 (siRNA 672 or 3014) and the luciferase
(control, siRNA Luc) are reported in Table 1.
In Situ Proximity Ligation Assay
Protein interactions in podocytes were studied using an In situ
Proximity Ligation assay Kit (DuolinkH) from Olink Bioscience,
Finland [32]. Cells transfected with the siRNA Luc or 672
(Table 1) and cultured on coverslips were fixed, permeabilized and
incubated with primary antibodies such as in immunofluorescence
assays. Next, the In situ Proximity Ligation assay was used as
recommended by the manufacturer. Briefly, cells were incubated
with secondary antibodies with attached nucleotides. If nucleotides
were closed (less than 30–40 nm), the addition of two more
nucleotides and the ligation resulted in the formation of a circular
DNA strand. After amplification of the DNA circle and
hybridization of fluorescence (563 nm) labelled complementary
oligonucleotide detection probes, protein interactions were visu-
alized with a confocal microscope (Leica) as a red dot.
Migration Assay
96 h after transfection (siRNA Luc or 3014 sequences), a
migration assay was performed on adherent and fully differenti-
ated cells (14 days after switching from 33uC to 37uC) in a 6 well
plate. For the migration assay, the medium was changed (for low
serum medium 1% fetal calf serum). 2 wounds per well were
realized with a sterile tip. Pictures were sequentially taken just
before and after the scrap (T0), 6, 12, 24, 48 hours with a light
microscope. Cells having migrated inside the wound were
counted.
Permeability Assay
96 h after cell transfection (siRNA Luc or 3014 sequences),
permeability assay was assessed by measuring the passage of
FITC-labelled dextran (Molecular weight: 70 kDa, InvitrogenH)
across a TranswellH seeded with podocytes 16 days before (2 days
of proliferation and 14 days of differentiation). Cells were starved
during 1 hour (medium replacement was performed in wells and
TranswellsH). Then, 100 ml of TranswellH and well medium was
removed. The volumes were replaced with 100 ml of serum free
medium containing 1 mg/ml of FITC-labelled dextran in the
TranswellH and with 100 ml of serum free medium containing
1 mg/ml of unlabelled dextran in the well. At 1, 2 and 3 hours,
100 ml of medium was removed from each well and replaced with
100 ml of serum free medium containing 100 mg/ml of unlabelled
dextran. Each sample was transferred in a 96 wells plate for
fluorescence measurement.
Cytotoxicity Assay
After 96 h of transfection (siRNA Luc or 3014), cytotoxicity was
assayed on differentiated cells. 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) was used at a 1/5 dilution.
Medium was removed. Cells were washed with Hank’s medium
and incubated with MTT solution for 3 h at 37uC. MTT solution
was removed and replaced by cell lysis buffer: DMSO (Dimethyl-
Figure 10. Schematic representation of the podocyte foot processes with putative IQGAP1 localization and interactions. Bottom:
schematic representation of two pedicels, joined by the slit diaphragm. Top: two enlargements are depicted representing possible IQGAP1
interactions at the slit diaphragm (right) and the podocyte apical (left) regions. Proteins highlighted in grey and italics correspond to proteins not
explored in this study. With the exception of nephrin, direct or indirect interactions between IQGAP1 and its partners remain to be demonstrated.
doi:10.1371/journal.pone.0037695.g010
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sulfoxyde). Samples were then transfered in a 96 well plate for
spectrophotometer measuring.
Proliferation Assay
After 96 h of transfection (siRNA Luc or 3014 sequences),
proliferation assayed on differentiated cells. Neutral red was used
at a 1/80 dilution in IMDM with 10% FCS. Medium was
removed. Cells were washed with Hank’s medium and incubated
with neutral red solution for 3 h at 37uC. Solution was removed
and replaced by cell lysis buffer: acetic acid (1%) with ethanol
(50%). Samples were then transfered in a 96 well plate for
spectrophotometer measuring.
Quantification of Adherent Cells
To appreciate the proportion of adherent cells, Sulforhodamine
B assay was done. We used the In vitro toxicology assay kit
Sulforhodamine B Based (Sigma-AldrichH) and followed the
manufacturer procedure.
Immunohistofluorescence
10 mm-thick kidney sections were deparaffined, hydrated and
treated for 30 min at 98uC with 10 mM citrate buffer, pH 6 for
antigen retrieval. Sections were washed in PBS and incubated for
30 min with 3% BSA in PBS to block non specific binding. Then
sections were incubated overnight at 4uC with primary antibodies
against IQGAP1 and nephrin at a 1/50 dilution in PBS (Table 2).
After several washes in PBS, sections were incubated for 1 h at
room temperature with appropriate secondary antibodies at a 1/
200 dilution in PBS (Table 3). After several washes in PBS, nuclei
were labelled with DAPI (dilution 1/1000 in PBS). Then sections
were mounted with Fluoromount-G (Southern Biotech, USA) and
analysed using a confocal microscope (Leica).
Statistical Analysis
Statistical significance was assessed either by parametric or non-
parametric tests, as appropriate with GraphPadH Software (La
Jolla, CA). Statistical significance was defined as p,0.05.
Supporting Information
Figure S1 Morphology of human cultured podocytes
and expression of nephrin, a podocyte specific marker.
(A) The morphology of human cultured podocytes was observed
by light microscopy: undifferentiated cells (left panel-33uC) and
differentiated cells (right panel-37uC). (B) Immunofluorescence of
nephrin in human cultured podocytes showed a diffuse cytoplas-
mic expression in undifferentiated cells (left panel-33uC) and a
Table 2. Characteristics of primary antibodies used in the study.
Antibodies Source Applications (Dilution) Origin
IQGAP1 Mouse mAb, clone AF4 IF (1/100) Upstate
Rabbit pAb, H-109 IH (1/500), IF (1/100) Santa Cruz
WB (1/1000), IP (2 mg/ml)
Nephrin Rabbit pAb, H-300 IF (1/50), WB (1/250) Santa Cruz
IP (3 mg/ml), IH (1/50)
Guinea pig IH (1/50) Acris
MAGI-1 Rabbit pAb, H-70 IF (1/100), WB (1/250), IP (3 mg/ml) Santa Cruz
CD2AP Rabbit pAb, H-290 IF (1/100), WB (1/250), IP (3 mg/ml) Santa Cruz
b-actin Mouse mAb, clone C4 IF (1/100), WB (1/10000) BD Bioscience
b-catenin Mouse mAb, clone 14 IF (1/100), WB (1/1000) BD Bioscience
Rabbit mAb IF (1/100), WB (1/1000), IP (3 mg/ml) Cell signaling
a-actinin-4 Rabbit pAb IF (1/100), WB (1/250), IP (3 mg/ml) Alexis
Podocalyxin Mouse mAb IF (1/100), WB (1/250), IP (3 mg/ml) Gift Pr Ronco
NCK 1-2 Rabbit pAb, C-19 IF (1/100), WB (1/250), IP (3 mg/ml) Santa Cruz
Rabbit mAb IF (1/100) Cell signaling
Podocin Rabbit pAb IF (1/100), WB (1/250), IP (3 mg/ml) Santa Cruz
TTP Rabbit pAb, H-120 IP (2 mg/ml) Santa Cruz
(Abbreviations: mAb=monoclonal Antibody, pAb=polyclonal Antibody, IH = immunohistochemistry, IF = Immunofluorescence, WB=Western blot,
IP = Immunoprecipitation).
doi:10.1371/journal.pone.0037695.t002
Table 3. Characteristics of the secondary antibodies used in
the study.
Antibodies Conjugate to Applications Origin
Goat anti rabbit IR Dye 680 WB LI-COR, Odyssey
IR Dye 800 WB LI-COR, Odyssey
Goat anti mouse IR Dye 680 WB LI-COR, Odyssey
IR Dye 800 WB LI-COR, Odyssey
Goat anti rabbit Alexa Fluor 594 IF, IH Molecular Probes
Alexa Fluor 488 IF, IH Molecular Probes
Goat anti mouse Alexa Fluor 488 IF Molecular Probes
Alexa Fluor 594 IF Molecular Probes
Goat anti guinea
pig
Alexa fluor 568 IH Molecular Probes
Swine anti rabbit HRP WB Dako
(Abbreviations: IH = immunohistochemistry, IF = Immunofluorescence,
WB=Western blot, IP = Immunoprecipitation).
doi:10.1371/journal.pone.0037695.t003
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focal membrane expression associated with a cytoplasmic labelling
in differentiated cells (right panel-37uC).
(TIF)
Figure S2 Western blot analysis of IQGAP1, nephrin,
MAGI-1, CD2AP, podocin, NCK 1/2, a-actinin-4, b-
catenin, podocalyxin and b-actin expression in cultured
podocyte extracts. Western blot analyses were performed on all
these proteins during podocyte differentiation. Protein extracts
were from undifferentiated (permissive temperature of 33uC, Day
0 (D0)) and differentiated (non-permissive temperature of 37uC,
Day 16 (D16)) cultured immortalized podocytes, and a second
human kidney lysate (HKL); MW: Molecular weight (kDa).
(TIF)
Figure S3 FAK expression in podocytes. Immunofluores-
cence of FAK showed a similar expression in control podocytes (A)
and in siRNA IQGAP1 transfected podocytes (B). Characteristics
of FAK antibody: rabbit antibody, dilution 1/100, Upstate
Biotechnology, Massachusetts, USA.
(TIF)
Figure S4 Nuclear staining in normal kidney tissue. In
conditions previously described, IQGAP1 labelling (green) and
nuclear staining with DAPI was performed. Labelling is
representative of normal kidney. Scale bar, 50 mm. Analysis was
performed with a confocal microscope. Microscope sections,
0.5 mm. Magnification, X40. Nephrin staining in normal kidney
tissue: In conditions previously described, nephrin labelling (red)
was performed. In normal glomeruli, nephrin staining (red) was
continuous around the glomerular basement membrane. Scale
bar, 50 mm. Analysis was performed with a confocal microscope.
Microscope sections, 0.5 mm. Magnification, X40.
(TIF)
Figure S5 IQGAP1 glomerular expression and localiza-
tion in normal kidney tissue. All sections from normal
kidneys (6) are figured. In normal glomeruli, IQGAP1 labelling
(green) was continuous, corresponding to podocytes. IQGAP1 was
also expressed in parietal epithelial, endothelial and distal tubular
cells. Nuclear staining with DAPI is also represented. Immuno-
histochemistry experiments were performed on paraffin sections
from normal kidneys (6). Analysis was performed with confocal
microscopy. Microscope sections, 0.5 mm. Magnification, X40.
(TIF)
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